Corcept Therapeutics
CORT
#2304
Rank
C$11.59 B
Marketcap
C$105.93
Share price
3.10%
Change (1 day)
-0.08%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$0.25 Billion

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are C$0.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.15 B37.55%
2022-12-31C$0.11 B81.17%
2021-12-31C$61.1 M-0.96%
2020-12-31C$61.7 M14.87%
2019-12-31C$53.71 M10.12%
2018-12-31C$48.78 M31.22%
2017-12-31C$37.17 M1.06%
2016-12-31C$36.78 M-20.61%
2015-12-31C$46.33 M5.03%
2014-12-31C$44.11 M-1.46%
2013-12-31C$44.77 M20.42%
2012-12-31C$37.17 M627.24%
2011-12-31C$5.11 M32.5%
2010-12-31C$3.85 M51.59%
2009-12-31C$2.54 M-27.01%
2008-12-31C$3.48 M16.13%
2007-12-31C$3 M-27.19%
2006-12-31C$4.12 M-0.59%
2005-12-31C$4.14 M89.35%
2004-12-31C$2.19 M-96.1%
2003-12-31C$56.1 M-18.77%
2002-12-31C$69.07 M2201.5%
2001-12-31C$3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$163.63 B 63,256.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$112.36 B 43,406.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$163.26 B 63,116.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$152.20 B 58,831.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$123.98 B 47,907.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$92.29 B 35,634.67%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$1.12 B 337.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.08 B 321.19%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$7.62 B 2,852.97%๐Ÿ‡บ๐Ÿ‡ธ USA